Increased Number of Submacular Hemorrhages as a Consequence of Coronavirus Disease 2019 Lockdown

Ophthalmol Retina. 2020 Dec;4(12):1209-1210. doi: 10.1016/j.oret.2020.06.027. Epub 2020 Jun 25.

Authors

Francesco Romano¹, Davide Monteduro¹, Matteo Airaldi¹, Federico Zicarelli¹, Salvatore Parrulli¹, Mariano Cozzi¹, Giovanni Staurenghi²

Affiliations

¹ Eye Clinic, Department of Biomedical and Clinical Sciences, Luigi Sacco Hospital, University of Milan, Milan, Italy.
² Eye Clinic, Department of Biomedical and Clinical Sciences, Luigi Sacco Hospital, University of Milan, Milan, Italy. Electronic address: giovanni.staurenghi@unimi.it.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Angiogenesis Inhibitors / therapeutic use
COVID-19 / epidemiology*
Choroidal Neovascularization / drug therapy
Choroidal Neovascularization / epidemiology
Female
Humans
Incidence
Intravitreal Injections
Italy / epidemiology
Male
Ophthalmology / statistics & numerical data
Quarantine
Retinal Hemorrhage / epidemiology*
SARS-CoV-2*
Tertiary Care Centers / statistics & numerical data
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Wet Macular Degeneration / drug therapy
Wet Macular Degeneration / epidemiology

Substances

Angiogenesis Inhibitors
VEGFA protein, human
Vascular Endothelial Growth Factor A